Officials say Paul Elmer was responsible for his Noblesville, Ind.-based company distributing over- and under-potent drugs to hospitals across the country.
Unaware of the drugs’ strength, nurses administered 13 infants overly-potent midazolam, causing some to overdose, according to the Indianapolis Star.
Mr. Elmer was found guilty of one charge of conspiracy and nine counts of adulterating drugs.
Read the full report here.
More articles on pharmacy:
Carcinogen concerns prompt Sandoz to halt global distribution of heartburn drug
DEA raids some West Coast Kaiser Permanente pharmacies
California biotech files for bankruptcy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.